Statistics for Aurinia Pharmaceuticals Inc (id:6450 AUPH)

Valuation metrics

Market cap

1.27B

Enterprise value

995.30M

Trailing P/E (ttm)

-16.41

Forward P/E

16.41

PEG ratio

16.41

Price/Sales (ttm)

5.76

Price/Book (mrq)

3.27

Enterprise Value/Revenue

4.52

Enterprise Value/EBITDA

2.01K

Overview

Shares outstanding

143.18M

Float

128.87M

Shares short

7.34M

% Held by insiders

0.07%

% Held by institutions

0.43%

Average volume (10 days)

1.56M

Average volume (90 days)

Price summary

52-Week low

4.71

52-Week high

9.74

52-Week change

-3.50%

Beta

1.46

50-Day moving average

7.40

200-Day moving average

6.08

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

October 23th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-10.23%

Operating margin

17.33%

Operational effectiveness

Return on assets

-2.16%

Return on equity

-5.78%

Income statement

Revenue (ttm)

1.54

Revenue per share (ttm)

1.54

Quarterly revenue growth (yoy)

Gross profit (ttm)

161.36M

EBITDA

495.00K

Net income to common (ttm)

-22,552,000.00

Diluted EPS (ttm)

-0.15

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

348.24M

Total cash per share (mrq)

2.43

Total debt (mrq)

87.85M

Total Debt/Equity (mrq)

22.64

Current ratio (mrq)

560.30%

Book value per share (mrq)

2.71

Cash flow

Cash flow statement

28.59M

Levered free cash flow (LFCF)

38.91M